Suppr超能文献

三指拨动开关:Krüppel 样因子 1 调节 γ-珠蛋白向β-珠蛋白基因转换。

Three fingers on the switch: Krüppel-like factor 1 regulation of γ-globin to β-globin gene switching.

机构信息

Blood and Bone Disease Program, Mater Research, Mater Hospital, Brisbane, Queensland, Australia.

出版信息

Curr Opin Hematol. 2013 May;20(3):193-200. doi: 10.1097/MOH.0b013e32835f59ba.

Abstract

PURPOSE OF REVIEW

Krüppel-like factor 1 (KLF1) regulates most aspects of erythropoiesis. Many years ago, transgenic mouse studies implicated KLF1 in the control of the human γ-globin to β-globin switch. In this review, we will integrate these initial studies with recent developments in human genetics to discuss our present understanding of how KLF1 and its target genes direct the switch.

RECENT FINDINGS

Recent studies have shown that human mutations in KLF1 are common and mostly asymptomatic, but lead to significant increases in levels of fetal hemoglobin (HbF) (α2γ2) and adult HbA2 (α2δ2). Genome-wide association studies (GWAS) have demonstrated that three primary loci are associated with increased HbF levels in the population: the β-globin locus itself, the BCL11A locus, and a site between MYB and HBS1L. We discuss evidence that KLF1 directly regulates BCL11A, MYB and other genes, which are involved directly or indirectly in γ-globin silencing, thus providing a link between GWAS and KLF1 in hemoglobin switching.

SUMMARY

KLF1 regulates the γ-globin to β-globin genetic switch by many mechanisms. Firstly, it facilitates formation of an active chromatin hub (ACH) at the β-globin gene cluster. Specifically, KLF1 conscripts the adult-stage β-globin gene to replace the γ-globin gene within the ACH in a stage-specific manner. Secondly, KLF1 acts as a direct activator of genes that encode repressors of γ-globin gene expression. Finally, KLF1 is a regulator of many components of the cell cycle machinery. We suggest that dysregulation of these genes leads to cell cycle perturbation and 'erythropoietic stress' leading to indirect upregulation of HbF.

摘要

目的综述

Krüppel 样因子 1(KLF1)调节红细胞生成的各个方面。许多年前,转基因小鼠研究表明 KLF1 参与了人类 γ-珠蛋白向 β-珠蛋白转换的控制。在这篇综述中,我们将把这些最初的研究与人类遗传学的最新进展结合起来,讨论我们目前对 KLF1 及其靶基因如何指导转换的理解。

最新发现

最近的研究表明,人类 KLF1 突变很常见,且大多无症状,但导致胎儿血红蛋白(HbF)(α2γ2)和成人 HbA2(α2δ2)水平显著升高。全基因组关联研究(GWAS)表明,三个主要位点与人群中 HbF 水平的升高有关:β-珠蛋白基因座本身、BCL11A 基因座以及 MYB 和 HBS1L 之间的位点。我们讨论了证据表明 KLF1 直接调节 BCL11A、MYB 和其他基因,这些基因直接或间接地参与γ-珠蛋白沉默,从而在血红蛋白转换中提供了 GWAS 和 KLF1 之间的联系。

总结

KLF1 通过多种机制调节γ-珠蛋白向β-珠蛋白的遗传转换。首先,它促进了β-珠蛋白基因簇中活性染色质中心(ACH)的形成。具体来说,KLF1 以特定阶段的方式促使成人阶段的β-珠蛋白基因取代 ACH 中的γ-珠蛋白基因。其次,KLF1 是编码γ-珠蛋白基因表达抑制剂的基因的直接激活剂。最后,KLF1 是细胞周期机制许多成分的调节剂。我们认为,这些基因的失调导致细胞周期紊乱和“红细胞生成应激”,从而间接上调 HbF。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验